Related Experiment Video
Updated: May 27, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Hirayama disease in children from North America
Partha S Ghosh1, Manikum Moodley, Neil R Friedman
1Pediatric Neurology Center, Children's Hospital, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Insights
Hirayama disease, a rare neurological disorder, affects young males in North America. Early diagnosis and cervical collar use are key for managing this condition.
Area of Science:
- Neurology
- Pediatric Neurology
Background:
- Hirayama disease is predominantly reported in Asia, with limited data from North America.
- This condition primarily affects adolescents and young adults, presenting with progressive weakness in the upper extremities.
Purpose of the Study:
- To describe the clinical characteristics and diagnostic findings of Hirayama disease in pediatric patients in North America.
- To emphasize the importance of recognizing this rare condition for timely intervention.
Main Methods:
- Retrospective chart review of patients under 18 diagnosed with Hirayama disease over 10 years at a single center.
- Analysis of clinical presentation, electromyography (EMG) findings, and cervical magnetic resonance imaging (MRI) results.
Main Results:
- Six pediatric patients (4 boys, mean age 15.1 years) were diagnosed with Hirayama disease.
- Common symptoms included unilateral/bilateral asymmetric distal upper extremity weakness, oblique amyotrophy, and cold paresis.
- EMG revealed denervation in C8/T1 and C7 myotomes, sparing C5-C6. Cervical MRI was abnormal in 3 patients.
- Symptoms progressed over a mean of 16.5 months; treatment involved cervical collars.
Conclusions:
- Hirayama disease can occur in North American pediatric populations, presenting with characteristic upper extremity weakness.
- Increased awareness among pediatric neurologists is crucial for early diagnosis and to avoid unnecessary investigations.
- Cervical collar treatment may help manage symptom progression.
Abstract:
Hirayama disease has been mainly reported from Asia; only a few cases are from the Western hemisphere, particularly North America. This is a retrospective chart review of patients < 18 years, diagnosed with Hirayama disease from a single center over 10 years. We diagnosed 6 children (4 boys), 15.1 ± 1.2 years of age. Symptom onset was 3 months to 3 years before presentation. All had unilateral or bilateral asymmetric distal upper extremity weakness without objective sensory loss. Oblique amyotrophy and cold paresis were noted in 5. On electromyography, acute-on-chronic denervation was most frequently noted in cervical-8 (C8) and thoracic-1 (T1) myotomes followed by cervical-7 (C7) myotome in both upper limbs, sparing C5-C6 myotomes. Cervical magnetic resonance imaging (MRI) was abnormal in 3. Symptoms progressed over a mean of 16.5 months. Treatment consisted of placement of cervical collar. Heightened awareness of this entity among pediatric neurologists in North America will lead to early diagnosis and intervention, avoiding unnecessary investigations.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Huntington Disease l: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Encephalitis l: Introduction
Lysosomal Hydrolases